
After the first documented case in a human, the World Health Organization currently sees no risk of a wider spread.
AI-generated summary
The Shamonda virus has so far been primarily detected in animals such as cattle and horses. Transmission occurs through biting midges, whose activity decreases in cooler months.
Geneva. After the first documented case of Shamonda virus in a person, the World Health Organization (WHO) does not expect a major infection. Based on available information and knowledge about closely related viruses, the infection in France is an isolated case in humans, said WHO spokesman Christian Lindmeier. “And it is currently unlikely that there will be further spread,” he said in Geneva.
However, the spokesman pointed out that the WHO had not yet prepared a formal risk assessment. The Shamonda virus had previously been found in animals such as cattle and horses. According to the French Ministry of Agriculture, the first known Shamonda patient died in early October. He therefore suffered from a severe immune deficiency.
“If the immune system is severely weakened, the defense against infectious agents is significantly impaired,” said Martin Beer from the Friedrich Loeffler Institute (FLI) in Greifswald. Infection and virus multiplication could then occur much more easily. This is of great importance when assessing this case, emphasized the expert from the Federal Research Institute for Animal Health.
It is currently believed that the infection was caused by the bite of a biting midge - a small mosquito - in eastern France. Animal infections with the Shamonda virus were reported there in the spring and summer.
WHO spokesman Lindmeier said that the transmission of viruses by biting midges generally decreases in the cooler seasons. According to the FLI, biting midges are native to Central Europe and are generally active from April to November. They reproduce optimally at 25 to 35 degrees Celsius. Temperatures of more than 12 to 15 degrees are necessary for the virus to multiply in insects.

A phase 3 study by Moderna and MSD shows that personalized mRNA vaccination reduces the risk of recurrence in black skin cancer by 42 percent. However, experts urge caution because data on overall survival after 25 months does not yet show a clear benefit.

Following a ruling by the Federal Constitutional Court in 2020, over 30 professional societies have published new guidelines on how to deal with requests for suicide assistance. It contains 45 criteria for assessing free responsibility.

German health insurance companies estimate the damage caused by incorrect billing in the healthcare system to be in the double-digit billion range. Since official data is missing, the National Association of Statutory Health Insurance Funds has started its own study and is calling for tougher controls.

Germany's health insurance companies and politicians are calling for medical appointments to be made purely based on medical necessity instead of insurance status in order to end discrimination and long waiting times for statutory health insurance patients.
Researchers at the University of Bochum are growing three-dimensional organoids from tumor cells from pancreatic cancer patients in order to test personalized chemotherapy in the laboratory and improve the chances of treatment.

A dispute breaks out between the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds over the effects of the Statutory Health Insurance Contribution Rate Stabilization Act on the availability of outpatient doctor's appointments for those with statutory health insurance.